Healthy Skepticism Library item: 15729
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Lawmakers, Drug Makers Spar Over Pharma Patent Settlements
The Wall Street Journal 2009 Jun 3
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38351859#
Abstract:
Executives for Mylan Inc. (MYL) and Endo Pharmaceuticals Inc. (ENDP) faced a grilling on Capitol Hill Wednesday from lawmakers who support legislation to bar pharmaceutical patent settlements that delay the introduction of generic drugs.
Critics in Congress and at the U.S. Federal Trade Commission say the deals are anticompetitive because branded drug makers pay their generic counterparts to abandon patent challenges that could lead to early market entry of competing generic medicines.
“Generic companies are getting paid handsomely to sit on the sidelines,” said Richard Feinstein, head of the FTC’s Bureau …
